Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Clinical trial NCT01951586 · COMPLETED
Trial details
- NCT number
- NCT01951586
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-31
- Primary completion
- 2016-07-29
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.